Vincenzo Brandi
Research Subjects
Research Interests
Vincenzo Brandi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anna Maria Martone
Department of Geriatrics, Orthopedics and Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy
1 shared publication - Davide Liborio Vetrano
Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden
1 shared publication - Eva Topinkova
Department of Geriatrics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
1 shared publication - Fabrizia Lattanzio
Scientific Direction, IRCCS INRCA, 60127 Ancona, Italy
1 shared publication - Francesco Landi
Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
1 shared publication - Graziano Onder
Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
1 shared publication
Latest Publications
- 1 March 2015
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 21 (13) , 1659-1664
Treating Heart Failure in Older and Oldest Old Patients.
Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacological and non-pharmacological approaches has determined an improvement in survival of patients with HF, leading to the selection of an older and frailer population with HF. The clinical approach to such a complex population should require clear indications to assist physicians during their daily practice, but there is a huge lack of evidence regarding the treatment of HF in the oldest among the elderly patient population. In addition, the co-occurrence of specific conditions that are extremely prevalent in older individuals with HF, such as cognitive impairment, comorbidities, and polypharmacy, can further complicate the clinical man agement of this condition. Thus, a multidisciplinary approach with the goal of recognizing and treating conditions associated with HF may be necessary to improve the quality of care and to reduce expenditures. Several studies have assessed the effect of a comprehensive geriatric assessment and management on quality of care in HF patients, demonstrating a substantial improvement in patient outcomes and administration of the appropriate drug treatment.
- 1 March 2015
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 21 (13) , 1659-1664
Treating Heart Failure in Older and Oldest Old Patients.
Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacological and non-pharmacological approaches has determined an improvement in survival of patients with HF, leading to the selection of an older and frailer population with HF. The clinical approach to such a complex population should require clear indications to assist physicians during their daily practice, but there is a huge lack of evidence regarding the treatment of HF in the oldest among the elderly patient population. In addition, the co-occurrence of specific conditions that are extremely prevalent in older individuals with HF, such as cognitive impairment, comorbidities, and polypharmacy, can further complicate the clinical man agement of this condition. Thus, a multidisciplinary approach with the goal of recognizing and treating conditions associated with HF may be necessary to improve the quality of care and to reduce expenditures. Several studies have assessed the effect of a comprehensive geriatric assessment and management on quality of care in HF patients, demonstrating a substantial improvement in patient outcomes and administration of the appropriate drug treatment.